Regenesys

Gaston Geenslaan 1

3001 Heverlee

BE

Regenesys

Foundation date

17-10-2005

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

ReGenesys BVBA is a wholly-owned subsidiary of Athersys, Inc. (NASDAQ: ATHX), a biotechnology company in Cleveland, Ohio, U.S.A., that is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product initially for disease indications in the neurological, cardiovascular, inflammatory and immune areas.  Athersys has several ongoing clinical trials to evaluate its MultiStem product candidate.

Latest news

  • Mayne Pharma and Mithra announce TGA approval of Nextstellis® oral contraceptive

    22 hours ago

  • Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    22 hours ago

  • S-Biomedic announces topline results of a successful clinical study in acne

    Friday November 26th 2021